60 Degrees Pharmaceuticals Gross Margin Growth & History (SXTP)

60 Degrees Pharmaceuticals's gross margin was 22.26% for fiscal 2025.

View full 60 Degrees Pharmaceuticals company overview

60 Degrees Pharmaceuticals annual gross margin history

60 Degrees Pharmaceuticals annual gross margin

Fiscal yearPeriod endedGross marginChange (percentage points)
20252025-12-3122.26%−14.42 pp
20242024-12-3136.67%+123.82 pp
20232023-12-31−87.15%+6.56 pp
20222022-12-31−93.71%

60 Degrees Pharmaceuticals gross margin trends

Between the periods ended 2022-12-31 and 2025-12-31, 60 Degrees Pharmaceuticals's gross margin increased from −93.71% to 22.26%, a change of +115.96 percentage points. The latest reported quarter, Q2 2026, shows 27.32%.

About the metric

What gross margin means

Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.

Calculation and source

How gross margin is calculated

TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review 60 Degrees Pharmaceuticals source filings ↗

Community posts

It’s quiet here.

No posts about SXTP yet. Start the conversation.

Write the first post